REG - Microsaic Systems - Restoration & Update

Microsaic SystemsAnnouncement

16/01/2024 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240116:nRSP7777Za&default-theme=true

RNS Number : 7777Z  Microsaic Systems plc  16 January 2024

16 January 2024

Microsaic Systems plc

("Microsaic" or the "Company")

 

Restoration of Company's Shares to Trading on AIM,

Admission of Placing Shares

and TVR Update

 

Capitalised terms in this announcement carry the same meaning as in the
Circular

or subsequent announcements, unless the context indicates otherwise

 

Microsaic Systems plc (AIM: MSYS), the developer of micro-electronic
instruments and analytical solutions, announce the following updates.

 

Restoration

 

Following the publication of the Annual Report and Interim Results at 7.00
a.m. this morning, its Ordinary Shares are expected to be restored to trading
on AIM at 7.30 a.m. today.

 

Admission of Placing Shares & Directors' Participation

 

The Company confirms that the 169,000,000 Placing Shares are expected to be
admitted to trading on AIM at 8.00 a.m. today.

 

In addition, following the publication of the Annual Report and Interim
Results, the Company confirms that Bob Moore and Nigel Burton have now entered
into contractual obligations to subscribe for 9,040,000 and 2,000,000 Placing
Shares respectively, in line with the expectations set out in the Conditional
Placing announcement issued yesterday afternoon.

 

Total voting rights

 

Following Admission, the Company will have 179,178,185 Ordinary Shares in
issue. The Company does not hold any shares in treasury. Therefore, from
Admission, the total voting rights in the Company will be 179,178,185.

 

From Admission, the figure of 179,178,185 may be used by shareholders as the
denominator for the calculations by which they will determine whether they are
required to notify their interest in, or a change to their interest in, the
share capital of the Company pursuant to the FCA's Disclosure Guidance and
Transparency Rules.

 

This announcement contains inside information as stipulated under the UK
version of the Market Abuse Regulation No 596/2014 which is part of English
Law by virtue of the European (Withdrawal) Act 2018, as amended. On
publication of this announcement via a Regulatory Information Service, this
information is considered to be in the public domain.

 

Enquiries:

 Microsaic Systems plc                            +44 (0) 20 3657 0050

 Bob Moore, Acting Executive Chairman             via TPI

 Singer Capital Markets                           +44 (0)20 7496 3000

(Nominated Adviser & Joint Broker)

 Aubrey Powell / Angus Campbell / Oliver Platts

 Turner Pope Investments (TPI) Limited            +44 (0) 20 3657 0050

(Joint Broker)

 Andy Thacker / James Pope

 

About Microsaic Systems

Microsaic has over 20 years' experience in microelectronics and development of
instrumentation. The Company has a robust and innovative patent portfolio in
cutting-edge technology designed and developed for "Industry 4.0" application
serving markets in diversified Industries, Human and Environmental Health.
Microsaic's system solutions have enabled analytical detection and
characterisation at the point-of-need, whether within a conventional
laboratory setting, or within a bioprocessing facility for continuous
detection of data at multiple steps in the process workflow.

 

Microsaic's products and solutions are commercially available through global
markets via a network of regional and local partners, targeting its core
laboratory, manufacturing and point-of-need applications.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCZZGMMZVLGDZG